[1]
A. U. Gavrić, J. Ocvirk, and P. Jaki Mekjavic, “OCULAR CHANGES IN METASTATIC MELANOMA PATIENTS TREATED WITH MEK INHIBITOR COBIMETINIB AND BRAF INHIBITOR VEMURAFENIB”, Radiol Oncol, vol. 52, no. 2, May 2018.